iRhythm Holdings, Inc.
IRTCNasdaq
$110.88
↓ -3.9%Jul 17 close · end-of-day
Price
1Y↓ -28.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$3.6B
Enterprise Value
$3.1B
P/E
—
P/S
4.6
P/B
22.4
EV/EBITDA
—
PEG
—
FCF Yield
0.5%
Dividend Yield
—
Revenue (TTM)
$787.9M
Net Income (TTM)
-$28.2M
Free Cash Flow (TTM)
$18.8M
Gross Margin
71.0%
Operating Margin
-5.2%
Net Margin
-3.6%
ROE
-17.5%
ROIC
—
Debt / Equity
—
Net Cash
$549.6M
Return 1Y
—
Company profile
iRhythm Technologies, Inc. provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company's Zio XT and AT monitors, single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats.
- CEO
- Quentin S. Blackford
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 1,790
- Headquarters
- California
- Website
- irhythmtech.com
Management & directors
- Freeman Sean ClintonEVP, Strategy & Corp Devt
- Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
- Rosenbaum Marc W.Chief Accounting Officer
- Shrishrimal SumiEVP, Chief Risk Officer
- Blackford Quentin S.President and CEO
- Patterson ChadCHIEF COMM & PRODUCT OFFICER
- Lawrence BrianChief Technology Officer
- Smith MervinEVP Strategic Business Ops
- Murphy Patrick MichaelCBO and CLO
- Wilson Daniel G.Chief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
IRTC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$199.4M↑ +25.7%
Diluted EPS-$0.43↓ -55.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $265.2M | $322.8M | $410.9M | $492.7M | $591.8M | $747.1M |
| Gross profit | $194.9M | $213.6M | $281.6M | $331.8M | $407.5M | $527.3M |
| Operating income | -$43.7M | -$99.9M | -$113.8M | -$125.2M | -$115.5M | -$57.4M |
| Net income | -$43.8M | -$101.0M | -$116.0M | -$123.0M | -$113.0M | -$45.0M |
| Diluted EPS | -$1.58 | -$3.46 | -$3.88 | -$4.04 | -$3.63 | -$1.39 |
| Operating cash flow | -$13.8M | -$37.8M | -$23.0M | -$50.1M | $3.4M | $80.9M |
| Free cash flow | -$27.3M | -$65.8M | -$52.8M | -$90.5M | -$30.6M | $34.5M |
| Gross margin | 73.5% | 66.2% | 68.5% | 67.3% | 68.9% | 70.6% |
| Operating margin | -16.5% | -31.0% | -27.7% | -25.4% | -19.5% | -7.7% |
| Net margin | -16.5% | -31.3% | -28.2% | -25.0% | -19.1% | -6.0% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $148.0M | $147.5M | $164.3M | $158.7M | $186.7M | $192.9M | $208.9M | $199.4M |
| Gross profit | $103.5M | $101.5M | $115.1M | $109.2M | $132.9M | $137.1M | $148.1M | $141.4M |
| Operating income | -$23.0M | -$50.3M | -$4.1M | -$32.6M | -$18.7M | -$8.4M | $2.3M | -$16.2M |
| Net income | -$20.1M | -$46.2M | -$1.0M | -$30.7M | -$14.2M | -$5.2M | $5.1M | -$13.9M |
| Diluted EPS | -$0.65 | -$1.48 | -$0.03 | -$0.97 | -$0.44 | -$0.16 | $0.18 | -$0.43 |
| Operating cash flow | $11.8M | $24.3M | $19.2M | -$7.9M | $27.7M | $34.9M | $26.2M | -$26.2M |
| Free cash flow | $3.4M | $15.5M | $12.4M | -$17.3M | $17.3M | $20.1M | $14.5M | -$33.1M |
| Gross margin | 69.9% | 68.8% | 70.0% | 68.8% | 71.2% | 71.1% | 70.9% | 70.9% |
| Operating margin | -15.5% | -34.1% | -2.5% | -20.5% | -10.0% | -4.4% | 1.1% | -8.1% |
| Net margin | -13.6% | -31.3% | -0.6% | -19.3% | -7.6% | -2.7% | 2.5% | -7.0% |
Company news
Jul 16, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-02 | Turakhia Minang· CHIEF MED/SCI OFCR EVP ADVTECH | Sale | 1,423 | $124.71 | $177,462.33 | filing |
| 2026-07-02 | Freeman Sean Clinton· EVP, Strategy & Corp Devt | Sale | 918 | $124.71 | $114,483.78 | filing |
| 2026-06-02 | Shrishrimal Sumi· EVP, Chief Risk Officer | Sale | 1,716 | $108.19 | $185,652.50 | filing |
| 2026-06-02 | Rosenbaum Marc W.· Chief Accounting Officer | Sale | 729 | $108.19 | $78,870.00 | filing |
| 2026-05-29 | Freeman Sean Clinton· EVP, Strategy & Corp Devt | Award | 273 | $96.82 | $26,430.50 | filing |
| 2026-05-29 | Blackford Quentin S.· President and CEO | Award | 178 | $96.82 | $17,233.07 | filing |
| 2026-05-29 | Rosenbaum Marc W.· Chief Accounting Officer | Award | 178 | $96.82 | $17,233.07 | filing |
| 2026-05-29 | Patterson Chad· CHIEF COMM & PRODUCT OFFICER | Award | 177 | $96.82 | $17,136.26 | filing |
| 2026-05-29 | Turakhia Minang· CHIEF MED/SCI OFCR EVP ADVTECH | Award | 137 | $96.82 | $13,263.66 | filing |
| 2026-05-29 | Shrishrimal Sumi· EVP, Chief Risk Officer | Award | 133 | $96.82 | $12,876.40 | filing |
| 2026-05-27 | MCGINNIS KAREN K | Award | 1,573 | $0.00 | $0.00 | filing |
| 2026-05-27 | Bairey Merz Cathleen Noel | Award | 1,573 | $0.00 | $0.00 | filing |
| 2026-05-27 | Bodaken Bruce G. | Award | 1,573 | $0.00 | $0.00 | filing |
| 2026-05-27 | Ling Karen | Award | 1,573 | $0.00 | $0.00 | filing |
| 2026-05-27 | OBOYLE KEVIN C | Award | 1,573 | $0.00 | $0.00 | filing |
| 2026-05-27 | TALWALKAR ABHIJIT Y | Award | 1,573 | $0.00 | $0.00 | filing |
| 2026-05-27 | YOOR BRIAN B | Award | 1,573 | $0.00 | $0.00 | filing |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Sale | 2,293 | $118.02 | $270,611.38 | filing |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Sale | 1,147 | $119.16 | $136,671.59 | filing |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Sale | 940 | $116.05 | $109,090.95 | filing |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Sale | 642 | $116.98 | $75,101.93 | filing |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Buy | 5,312 | $10.71 | $56,891.52 | filing |
| 2026-05-11 | TALWALKAR ABHIJIT Y | Sale | 290 | $120.53 | $34,953.70 | filing |
| 2026-05-04 | LAWRENCE BRIAN· Chief Technology Officer | Sale | 1,014 | $120.80 | $122,491.20 | filing |
| 2026-03-16 | Smith Mervin· EVP Strategic Business Ops | Sale | 2,585 | $114.30 | $295,465.50 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.